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Abstract 
Background:  The   incidence   of   inappropriate   therapy   from   implantable   cardioverter 
defibrillators (ICDs) has been reduced by programming ventricular arrhythmia discriminators 
(VAD)   on   at   the   time   of   implant.                                                            
Objective:  To determine which VAD is most effective in preventing inappropriate therapy.
Methods  and  Results:   Dual  chamber   ICD  (n=48)   or  cardiac  resynchronization  therapy 
defibrillator (CRT-D) (n=55) implantation was performed in 103 patients (M=94, F=9). Patients 
were followed prospectively for therapy events (shock or anti-tachycardia pacing) for a mean 
362±289 days.  Events were correlated with clinical characteristics and VAD programming.  Of 
the 103 pts followed, 11 received inappropriate therapy (IT), 15 received appropriate therapy 
(AT), and 77 received no therapy (NT). In the AT and IT groups, a total of 207 events 
(ATP=171,  shock=36)   were   observed.   A   total   of   sixty-four   electrograms   (EGMs)   were 
analyzed.   Programming VADs "ON" versus "OFF" reduced the incidence of IT events 
compared to those receiving AT or NT events (p<.01), with a trend in fewer patients receiving 
IT (31.3% "ON" vs 55.6% "OFF", p = 0.131).  Programming atrial fibrillation (AF) detection 
ON resulted in fewer patients receiving IT compared to those receiving AT or NT (3.6% vs 19%, 
p<.05). Furthermore, programming AF or AFL algorithms "ON", resulted in overall fewer 
episodes   of   IT   therapy   (p<.01).                                                                    
Conclusions:  AF or AFL discriminators significantly reduced the incidence of IT, and were 
predominantly responsible for the benefits from VAD programming observed in this study.  
Activating these features as part of routine ICD or CRT-D programming may provide a simple 
and effective alternative to the use of more complex and multiple VAD strategies.
Key Words: Implantable Cardiac Defibrillators, Inappropriate Therapy, Ventricular Arrhythmia 
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Background
               The incidence of inappropriate therapy in patients with implantable cardioverter 
defibrillators (ICDs) has been well documented1,2. The incidence ranges from 15-40% and often 
occurs within the first 6 months of follow-up2. Inappropriate shocks have been correlated with a 
decrease in the quality-of-life (QOL) and may have negative psychological consequences3.  
            The high incidence of inappropriate therapy has led to the development of ventricular 
arrhythmia discriminators (VADs). Although VAD programming has resulted in a reduced 
inappropriate therapy (IT) in patients with single chamber or dual chamber ICDs4, the benefit of 
VAD programming in patients receiving cardiac resynchronization therapy defibrillator (CRT-
D)   remains   unknown.                                                              
            The benefit of VAD programming in patients with CRT-Ds may be more pronounced, 
since the incidence of IT in patients with CRT-D was quite high (11%) in the MIRACLE-ICD 
trial5.     In addition, the rare pro-arrhythmic effect of biventricular pacing has also been 
documented in select patients with CRT-D devices6  and may lead to increased ventricular 
arrhythmia   burden   in   these   patients.                                                            
            VAD programming is often at the discretion of the implanting physician and some 
physicians enable discriminators only after inappropriate therapy has been delivered7.  Though 
implanting physicians have a choice of which of the VADs algorithms to be programmed on, it 
remains unclear which, if any, single discriminator is more effective in preventing IT.           
            We hypothesized that programming VAD on at the time of CRT-D implantation would 
decrease the number of IT events. In addition, we set forth to determine whether a particular 
VAD would be more effective in preventing IT. These results would have important implications 
for routine programming of both ICD and CRT-D therapy.                                             
Methods
            This study was approved by the joint University of California/Veterans Administration 
Medical Center, San Diego, Institutional Review Board for human investigation. Consecutive 
patients who underwent clinically approved dual chamber ICD or CRT-D implantation between 
January 2001 and April 2004 were followed prospectively. Dual chamber ICD implantation 
consisted of insertion of an atrial bipolar electrode and a right ventricular bipolar electrode. 
CRT-D device configuration at implantation consisted of a left ventricular unipolar electrode 
combined with a bipolar right ventricular pace/sense electrode connected with a "Y" adapter to a 
single ICD ventricular port or to a separate left and right ventricular ports and an atrial bipolar 
electrode. VADs were programmed individually according to clinical characteristics and 
physician preference (Table 1).  Baseline patient clinical data, 12 lead ECG and implant data 
and settings were recorded.
Table 1. Examples of Ventricular Arrhythmia Discriminators (VADs)
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Statistical   Analysis                                                        
               Continuous variables are reported as the mean ± standard deviation.   Dichotomous 
variables are reported as percentages and were compared using the chi-square and fisher exact 
test.  A p value ≤.05 was considered statistically significant.  Logistic regression was used to 
predict   the   power   of   different   variables   in   a   multivariate   analysis.                        
 
Follow-up
               Data obtained during routine ICD/CRT-D interrogation during regularly scheduled 
follow-up visits at 3, 6, 12, and 18 months, were analyzed with respect to appropriate vs. 
inappropriate arrhythmia discrimination and therapy. An inappropriate therapy event was 
defined as ATP or shock delivered due to rhythms that were incorrectly characterized by the 
device. Each event was considered an independent event even if it occurred in the same patient. 
All   therapy   events   documented   by   intracardiac   electrograms   (EGMs)   were   evaluated 
independently by two electrophysiologists and classified as inappropriate or appropriate based 
on data retrieved from the CRT-D at the time of routine follow-up. The index arrhythmia, 
therapy  delivered,  and  resultant  rhythm  were  recorded,  and  any  device  reprogramming, 
including VAD programming, performed during follow-up was noted.                          
Results
Patient   Characteristics                                                      
            One hundred and seven patients who received ICD or CRT-D with appropriate follow up 
in our institution were identified. Three patients receiving devices without an atrial lead and one 
patient who received both inappropriate and appropriate therapy were excluded from analysis. 
Baseline characteristics for the 103 patients undergoing ICD/CRT-D implantation included in 
the study are listed in Table 2, including those in patients who received AT (n=15) and IT 
(n=11). There were no statistically significant differences in baseline characteristics, including 
medication usage. Programmable VAD algorithms included in this analysis are listed in Table 2. 
VADs were programmed "ON" in 78/103 (75.7%) patients at the time of implant.
Follow-up   Period                                                      
            During a mean follow-up of 362 ± 289 days, 15 (14.5%) patients received appropriate 
therapy, 11 (10.7%) patients received inappropriate therapy (Table 3), and 77 (74.8%) patients 
received no therapy. Of the 26 patients receiving therapy, a total of 207 therapy events 
(ATP=171, shock=36) were observed. Of these 207 therapy events, 64 available EGMS were 
analyzed by two independent electrophysiologists. Forty (62.5%) events were appropriate, 
whereas 24 (37.5%) were inappropriate. Inappropriate therapy events were significantly more 
common (χ2; p=0.01) when VAD was turned off (5/24, 20.8%) versus on (6/79, 7.6%).
Individual Ventricular Arrhythmia Discriminators                                                                     
             Programming atrial fibrillation (AF) ON versus OFF resulted in significantly fewer 
patients receiving IT compared to those receiving AT or NT (3.6% vs 19%, p<.05). Furthermore, 
among individual ATP or shock events analyzed by EGM, programming AF or AFL "ON" 
(p<0.001; for both) reduced IT events. Onset, stability, V>A, sinus tachycardia, and algorithms 
did not show additional benefit in reducing inappropriate therapy. We did not analyze the 
morphology criteria as there were very few patients with this feature available at the time of the 
study.
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Table 2. Patient Characteristics
ACEI/ARB = angiotensin converting enzyme inhibitor/angiotensin receptor blocker, AA drugs  
= antiarrhythmic drugs,  CAD = coronary artery disease, F/U = followup, Hx = history, LVEF = 
left ventricular ejection fraction
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Table 3.  Inappropriate Therapy Events
ST=   sinus   tachycardia;   AFIB=   atrial   fibrillation;   AFL=   atrial   flutter;   VT=   ventricular 
tachycardia; VF= ventricular fibrillation; DC= double counting; ATP= anti-tachycardia pacing; 
DCCV= direct current cardioversion; VADs= ventricular arrhythmia discriminators;  A =  Sinus 
Tachycardia, B = Stability, C = Onset, D = Ventricular>Atrial rate, E = Atrial Fibrillation or 
Atrial Fibrillation Rate Threshold, F = Atrial Flutter, G =  Supraventricular Tachycardia criteria, 
H =  Morphology  
Predictors of Inappropriate vs. Appropriate Therapy                                                 
            Baseline clinical differences between patients receiving any (not shown), inappropriate, 
or appropriate therapy (Table 2) were not statistically different (p=NS).                                
Safety
               In this analysis, none of the patients who had VADs turned on had ventricular 
arrhythmias   that   went   untreated.                                                         
Discussion
            This study showed that programming at least one VAD at the time of implant greatly 
reduced the incidence of inappropriate therapy events in patients receiving dual chamber ICDs 
or CRT-D. Despite the potential benefit of VAD programming, only 75.7% of patients had a 
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VAD programmed on at the time of implant. This has important clinical implications as CRT-D 
device implantation is becoming more widespread and more cardiologists are implanting CRT-D 
and routinely following patients post-implant.                                                              
               Programming VADs "ON" is safe and has not resulted in failure of detection of 
ventricular arrhythmias10. Therefore, given the potential benefit, we advocate that ICD/CRT-D 
implanting physicians should routinely consider programming VADs on at the time of implant. 
In addition, special consideration should be given to those patients with a history of underlying 
atrial arrhythmias, since these patients are more likely to receive inappropriate therapy11.
               Interestingly,  there   also  appears   to  be  a   time   dependent   relationship  between 
programming a VAD "ON" until first inappropriate therapy delivered as represented in Figure 1. 
This benefit appears to occur within the first year of implant and suggests that VAD 
programming "ON" provides protection from first IT.  
Figure 1.  Kaplan Meier analysis of time (days) until first inappropriate therapy (shock/anti-
tachycardia pacing in patients with any VAD programmed "ON" compared to those without any 
VAD programmed "ON". 
            Of the individual VADs available, AF and AFL discriminators significantly reduced IT 
events in this patient population (p<0.001 for each). It is plausible that the relatively high 
incidence of atrial arrthyhmias (26.2%) in this patient population, accounts for this finding, 
however, this is reflective of atrial arrhythmias found in the similar patient populations.   
            Individual discriminators differ between device manufacturers and are often comprised 
of multiple algorithms based on the atrial rate versus ventricular rate, the occurrence of P waves 
at different locations of the R-R interval, and P/R association. Unfortunately, our sample size 
precluded   a   comparison   of   AF   discrimination   algorithms   between   manufacturers.   
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            Previous studies have investigated whether clinical variables predict the delivery of 
appropriate versus inappropriate therapy in patients with ICDs. Nanthakumar, et.al. observed 
that patients with AF or NYHA Class I failure were at higher risk of inappropriate shocks11.  
More recently, in a study comprised of children and adolescents, Korte et. al, did not identify 
any clinical variable that predicted either appropriate or inappropriate therapy12.  In the present 
study, clinical baseline characteristics did not predict those patients receiving any therapy, 
whether   appropriate   or   not.                                                                    
Conclusions
               Programming VAD "ON" is safe after device implantation and results in reduced 
incidence of inappropriate therapy in patients receiving both prophylactic ICDs and those 
receiving CRT-D devices.  In terms of traditional individual discriminators, atrial fibrillation and 
atrial flutter algorithms may be the single most effective VAD for reducing inappropriate 
therapy given the high incidence of atrial arrhythmias in this population. However, newer 
algorithms incorporating QRS morphology warrant further investigation.                           
Limitations
            This a small study consisting of a predominantly male tertiary referral population and 
may not reflect a larger community population. Since this study was a prospective observational 
analysis, randomization to activation or inactivation of VAD was not performed, but should 
form the basis for a prospective randomized study to evaluate the optimal VAD in different 
patient populations. Furthermore, even though only a limited number of events are typically 
stored in any device; this analyzed sample is likely to be a fair representation of the entire 
burden of events. Lastly, discriminators including QRS morphology could not be fully evaluated 
since they were available in only a few patients in our study population. 
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